On Friday, the FDA authorised Neffy, the primary nasal spray for use as an emergency remedy for the tens of hundreds of thousands of Americans vulnerable to probably life-threatening allergic reactions. CBS News medical contributor Dr. Celine Gounder explains what to know concerning the new needle-free various to the EpiPen.
Each weekday morning, "CBS Mornings" co-hosts Gayle King, Tony Dokoupil and Nate Burleson deliver you the most recent breaking information, good dialog and in-depth function reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.
Subscribe to "CBS Mornings" on YouTube: https://youtube.com/CBSMornings
Watch CBS News 24/7: https://cbsnews.com/live/
Download the CBS News app: https://cbsnews.com/mobile/
Follow "CBS Mornings" on Instagram: https://instagram.com/cbsmornings/
Like "CBS Mornings" on Facebook: https://facebook.com/CBSMornings
Follow "CBS Mornings" on X: https://twitter.com/CBSMornings
Subscribe to our e-newsletter: https://cbsnews.com/newsletters/
Try Paramount+ free: https://paramountplus.com/?ftag=PPM-05-10aeh8h
For video licensing inquiries, contact: [email protected]
